Instrument for skin treatment
An apparatus configured to result in a penetration of one or more gasses into a dermis of biological skin, wherein the apparatus includes a fluid reservoir configured to contain an amount of a liquid in contact with a portion of a person's skin, and a nanobubble generator configured to inject nanobubbles into the liquid, wherein the nanobubbles contain the one or more gasses. The contact of the liquid containing the nanobubbles with the person's skin results in a cutaneous uptake of a gas contained in the nanobubbies into the person's skin, which may be beneficial in treating an ailment, such as diabetic peripheral neuropathy.
1. A method comprising:
generating gas nanobubbles in a liquid with a nanobubbler comprising a gas nozzle made of a porous ceramic material, wherein the porous ceramic material does not include any carbon; and
contacting the liquid containing the gas nanobubbles with a person's skin, wherein the contacting of the liquid containing the gas nanobubbles with the person's skin results in a cutaneous uptake of a gas contained in the gas nanobubbles.
2. The method as recited in claim 1 , wherein the gas is selected from the group consisting of oxygen, carbon dioxide, ozone, nitrogen, hydrogen, environmental air, and any combination thereof.
3. The method as recited in claim 1 , wherein the liquid is selected from the group consisting of water, oil, saline, a gel, a cosmetic cream, a lotion, an aerosol, and an ointment.
4. The method as recited in claim 1 , wherein the liquid has a viscosity in a range greater than 100,000 cP.
5. The method as recited in claim 1 , wherein the gas nanobubbles comprise nanobubbles containing oxygen and nanobubbles containing carbon dioxide, wherein the contacting of the liquid containing the gas nanobubbles with the person's skin comprises alleviating nerve numbness associated with peripheral neuropathy.
6. The method as recited in claim 5 , wherein the contacting of the liquid containing the gas nanobubbles with the person's skin comprises alleviating symptoms associated with peripheral neuropathy through a penetration of the gas nanobubbles containing carbon dioxide sufficiently deep into the dermis to dilate the blood vessels that supply peripheral nerves and a supply of the gas nanobubbles containing oxygen to the nerves.
7. The method as recited in claim 1 , wherein the liquid further comprises a skin penetration agent configured to enlarge pores in the person's skin.
8. The method as recited in claim 7 , wherein the skin penetration agent is selected from the group consisting of dimethylsuphoxide, pyrolidones, lauric acid, linoleic acid, oleic acid, and any combination thereof.
9. The method as recited in claim 1 , wherein an average diameter of at least some of the gas nanobubbles is less than 100 nanometers.
10. The method as recited in claim 1 , wherein the gas nanobubbles contain a pharmaceutical medication, and wherein contacting the liquid containing the gas nanobubbles with a person's skin comprises either a sublingual or buccal administration.
11. The method as recited in claim 1 , wherein the liquid has a viscosity in a range greater than 600,000 cP.
12. The method as recited in claim 1 , wherein the contacting of the liquid containing the gas nanobubbles with the person's skin is performed without applying the liquid through a break in the person's skin.
13. The method as recited in claim 1 , wherein an average diameter of the gas nanobubbles is less than 200 nanometers.
14. The method as recited in claim 1 , wherein an average diameter of the gas nanobubbles is less than 90 nanometers.
15. The method as recited in claim 1 , wherein the gas nanobubbles contain oxygen, and wherein an average diameter of at least some of the gas nanobubbles is sufficiently small so that the oxygen is directly permeable through the person's skin to nerves in a dermis of the person's skin.
16. A method comprising:
generating gas nanobubbles in a liquid; and
contacting the liquid containing the gas nanobubbles with a person's skin, wherein the contacting of the liquid containing the gas nanobubbles with the person's skin results in a cutaneous uptake of a gas contained in the gas nanobubbles, wherein the liquid has a viscosity in a range greater than 600,000 cP, wherein the liquid having a viscosity in a range greater than 600,000 cP was infused with the gas nanobubbles by increasing a temperature of the liquid in order to lower its viscosity.